Case Presentation: A 63-year-old female with no prior oncologic history was found to have a right breast mass via ultrasound guided biopsy. Pathology showed invasive poorly differentiated metaplastic carcinoma triple negative breast cancer. She was started on neoadjuvant chemotherapy, including Keytruda (pembrolizumab) every 3 weeks. During therapy, she developed Grade 1 fatigue and anemia. Baseline [...]

Case Presentation: A 69yo man was seen in preop clinic before cystoprostatectomy for a very large bladder tumor that had excellent radiographic response to pembrolizumab. His recent history was notable for an episode of witnessed syncope 5 weeks prior attributed to dehydration in the setting of baseline, long-standing intermittent episodes of SVT. Outpatient ECHO and [...]

Case Presentation: A 56-year-old female with stage IIB T2N0M0, grade 3, and triple negative breast cancer, was treated with lumpectomy and neoadjuvant chemoimmunotherapy (dose-dense doxorubicin and cyclophosphamide followed by carboplatin/paclitaxel/pembrolizumab). This resulted in near-complete remission. However, evidence of residual disease was found and she was started on pembrolizumab and capecitabine for 3 months. She presented [...]

Case Presentation: A 55-year-old female with a history of renal cell carcinoma treated with left-nephrectomy and Pembrolizumab-immunotherapy presents with complaints of weakness, orthostatic hypotension, nausea, and vomiting with food aversion. She had been admitted with similar complaints 9 times since her left nephrectomy, each time having received full workups including extensive sub-specialty evaluations including cardiology, [...]